Trials / Conditions / Acute Respiratory Viral Infections
Acute Respiratory Viral Infections
5 registered clinical trials studyying Acute Respiratory Viral Infections.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI NCT03830905 | PHARMENTERPRISES LLC | Phase 2 |
| Completed | Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections NCT03707912 | Materia Medica Holding | Phase 4 |
| Completed | Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral I NCT03455491 | PHARMENTERPRISES LLC | Phase 2 |
| Completed | Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in C NCT03039621 | Materia Medica Holding | Phase 4 |
| Completed | Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Inf NCT04682444 | Joint Stock Company "Farmak" | Phase 2 / Phase 3 |